Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial (2022)
Attributed to:
Blood borne viruses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(21)00292-7
PubMed Identifier: 35189082
Publication URI: http://europepmc.org/abstract/MED/35189082
Type: Journal Article/Review
Parent Publication: The Lancet HIV
Issue: 5
ISSN: 2352-3018